New Products

Ocrelizumab for Multiple Sclerosis
Ocrelizumab for Multiple SclerosisThe FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
New Drug Review: Sarilumab
New Drug Review: SarilumabThe FDA approved Kevzara for RA patients.
Omnicell System Streamlines Medication ManagementNew technology is helping patients, nurses, and pharmacists alike.
Surescripts Expands Medication History ServiceMore information could help save lives.
New Product Uses Dual Approach to Dissolve Cerumen
New Product Uses Dual Approach to Dissolve CerumenNew product uses new technology to break down earwax
New Drug ReviewPlecanatide: Approved for Chronic Idiopathic Constipation
Sugammadex: The First Selective Relaxant Binding AgentSugammadex reverses vecuronium and rocuronium, two drugs used to facilitate endotracheal intubation in surgery.
A product for every hair-care needAmericans spend billions of dollars on products to address specific hair and scalp concerns each year—whether that be color, condition, or appearance.
A product for every hair-care needAmericans spend billions of dollars on products to address specific hair and scalp concerns each year—whether that be color, condition, or appearance.